Assetmark Inc. Sells 119,055 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Assetmark Inc. lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 82.9% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,489 shares of the company’s stock after selling 119,055 shares during the period. Assetmark Inc.’s holdings in Option Care Health were worth $767,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the company. UMB Bank n.a. increased its holdings in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC boosted its holdings in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares during the last quarter. SageView Advisory Group LLC bought a new stake in Option Care Health in the 1st quarter valued at $85,000. Finally, International Assets Investment Management LLC grew its holdings in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after purchasing an additional 2,757 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 1.2 %

Shares of NASDAQ:OPCH opened at $21.93 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52-week low of $21.64 and a 52-week high of $34.63. The company has a market capitalization of $3.73 billion, a PE ratio of 18.43, a price-to-earnings-growth ratio of 2.30 and a beta of 1.32. The company has a fifty day moving average of $28.82 and a 200-day moving average of $29.44.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The trade was a 8.58 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on OPCH shares. Barrington Research lowered their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Truist Financial reduced their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Finally, Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.